Palvella Therapeutics, Inc. (PVLA) Total liabilities 2014–2023
Palvella Therapeutics, Inc. (PVLA) total liabilities at each fiscal year-end, per SEC filings.
$11.4MFY2023 · since FY2014: $3.9M → $11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $11.4M | -83.1% |
| FY2022 | $67.6M | -34.3% |
| FY2021 | $102.8M | +39.0% |
| FY2020 | $74.0M | -17.6% |
| FY2019 | $89.7M | -11.5% |
| FY2018 | $101.4M | +9.8% |
| FY2017 | $92.4M | +838.9% |
| FY2016 | $9.8M | +248.6% |
| FY2015 | $2.8M | -26.7% |
| FY2014 | $3.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice